<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EA3EC91C-2792-4238-BACE-9989415DE803"><gtr:id>EA3EC91C-2792-4238-BACE-9989415DE803</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_09003"><gtr:id>8AD27C25-A646-47BD-A5D6-36DD684A3682</gtr:id><gtr:title>ERANET 1 NEURON 3: Identification of copy number variants in familial and pathologically proven PD</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_09003</gtr:grantReference><gtr:abstractText>One of the major initial impacts of the human genome project was how little we understood about genomic diversity. Over the past 2-3 years it has become clear that there is tremendous variation in the numbers of copies of a large proportion of the human genome. There are some striking examples of copy numbers leading to human disease. The best characterised in neurological disease is the rearrangements around PMP22 giving rise to CMT1a and hereditary liability to pressure palsies. In Parkinson?s disease, of the currently identified genes,
rearrangements have been found in most of these, including a-synuclein (1), parkin (2), and PINK1 (3). In fact for a-synuclein duplication or triplication is the commonest mutational mechanism. Copy number variation (CNVs) can be considered in 2 broad ways. First there are rare occurrences (as above) where the duplication or deletion of genomic region may lead to a highly penetrant ?mendelian? form of disease. In the second, there is the potential role of ?common? rearrangements in susceptibility to disease. In the case of PD the rearrangements
listed above were all found after classical positional cloning strategies had identified them as PD genes and it was during the genetic characterisation of these genes that the rearrangements were demonstrated. Recent advances in genetic technologies allows for a rapid, robust genome wide search for CNVs. We plan to screen our series of patients for CNVs. In essence we will look in our recessive families for CNV, with particular emphasis on homozygous rearrangements. This work complements the objectives of subproject 2. We are also aware that single heterozygous rearrangements can cause autosomal dominant disease (eg a-syn). Therefore, in parallel with subproject 1 we will interrogate our AD PD families. Finally the role of ?common? CNVs has not been assessed in PD and we will adopt a genome wide search in 400 cases of sporadic pathologically proven PD.</gtr:abstractText><gtr:technicalSummary>One of the major initial impacts of the human genome project was how little we understood about genomic diversity. Over the past 2-3 years it has become clear that there is tremendous variation in the numbers of copies of a large proportion of the human genome. There are some striking examples of copy numbers leading to human disease. The best characterised in neurological disease is the rearrangements around PMP22 giving rise to CMT1a and hereditary liability to pressure palsies. In Parkinson?s disease, of the currently identified genes,
rearrangements have been found in most of these, including a-synuclein (1), parkin (2), and PINK1 (3). In fact for a-synuclein duplication or triplication is the commonest mutational mechanism. Copy number variation (CNVs) can be considered in 2 broad ways. First there are rare occurrences (as above) where the duplication or deletion of genomic region may lead to a highly penetrant ?mendelian? form of disease. In the second, there is the potential role of ?common? rearrangements in susceptibility to disease. In the case of PD the rearrangements
listed above were all found after classical positional cloning strategies had identified them as PD genes and it was during the genetic characterisation of these genes that the rearrangements were demonstrated. Recent advances in genetic technologies allows for a rapid, robust genome wide search for CNVs. We plan to screen our series of patients for CNVs. In essence we will look in our recessive families for CNV, with particular emphasis on homozygous rearrangements. This work complements the objectives of subproject 2. We are also aware that single heterozygous rearrangements can cause autosomal dominant disease (eg a-syn). Therefore, in parallel with subproject 1 we will interrogate our AD PD families. Finally the role of ?common? CNVs has not been assessed in PD and we will adopt a genome wide search in 400 cases of sporadic pathologically proven PD.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-02-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>309300</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International Parkinson's disease consortium</gtr:description><gtr:id>0528F5D9-BCD8-4258-AC61-8CB2AF22A153</gtr:id><gtr:impact>Publication in Nature genetics and Hum Mol genetics and a further recent submission</gtr:impact><gtr:outcomeId>NRumZQXz5gQ-1</gtr:outcomeId><gtr:partnerContribution>Building international consortium</gtr:partnerContribution><gtr:piContribution>Principal UK contributor</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Protein Phosphorylation and Ubiquitylation Unit</gtr:department><gtr:description>protein phosphorylation in PD</gtr:description><gtr:id>9D43339D-B9C9-40DF-9748-2B37BD96689C</gtr:id><gtr:impact>Recent successful strategic award- Wellcome trust/MRC- neurodegenerative diseases</gtr:impact><gtr:outcomeId>3649F1336FC-1</gtr:outcomeId><gtr:piContribution>Integrated biochemical approach to evaluating kinases involved in parkinsons pathophysiology</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neurogenetics</gtr:department><gtr:description>International Parkinson's disease consortium</gtr:description><gtr:id>8BD25DE9-2C51-4344-A925-3CFAAF32566F</gtr:id><gtr:impact>Publication in Nature genetics and Hum Mol genetics and a further recent submission</gtr:impact><gtr:outcomeId>NRumZQXz5gQ-2</gtr:outcomeId><gtr:partnerContribution>Building international consortium</gtr:partnerContribution><gtr:piContribution>Principal UK contributor</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Parkinson's UK Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D68E93A-6657-4E63-989C-50143F1B1EED</gtr:id><gtr:impact>Details on the finding of 5 genes which are involved in Parkinson's disease

Picked up for UK press release</gtr:impact><gtr:outcomeId>pwDeMfuWAYp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuromedia Corner</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E69D9503-A1CE-4C2A-ACA4-A71B5B0DB104</gtr:id><gtr:impact>Interviewed for a webcast explaining the recent advances in the genetics of Parkinson's Disease. 


unknown</gtr:impact><gtr:outcomeId>S41ZPSnb7pi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E2C3B094-3FF9-4EDE-9DC1-25114CA3F547</gtr:id><gtr:impact>Information disseminated to the general public about how changes in PINK1 can lead to Parkinson's disease

Interest from PD society member visits to lab about the work that is being undertaken</gtr:impact><gtr:outcomeId>CibfhdwuxBi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Telegraph Article</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F332F2EE-D46C-4011-9D6F-2965C43152B3</gtr:id><gtr:impact>Press release of the findings of genetic studies of Parkinson's disease

Increased interest from general public on PD genetic research</gtr:impact><gtr:outcomeId>DWEiqNVTp1j</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>315000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2011 - PUK - Filling the genetic gaps in Parkinson's - nwood</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:fundingRef>G-1107</gtr:fundingRef><gtr:id>093AFF3E-6DC0-4B02-AFD1-D7B0B8966B30</gtr:id><gtr:outcomeId>VHz1yYNkbMo0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>129110</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2011 - MRC - Clinical Research Fellowship - amcneill</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9131A4CD-1AE2-4ABF-9C96-63651535B850</gtr:id><gtr:outcomeId>BnzearZyzMH0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>339000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2011 - NIHR - Equipment Grant - nwood</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>FC2B0AA3-452A-4F93-A18B-D17A61E835E2</gtr:id><gtr:outcomeId>CEuqNKYaTvh0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661636</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2011 - WT - Equipment Grant - nwood</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>96889C70-C28D-44CB-8D49-E157159C73CF</gtr:id><gtr:outcomeId>FK2fDHSwTsk0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Database of patients with copy number variation</gtr:description><gtr:id>F00D32D3-9C33-485C-8DC0-A0D03D1C2BD3</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:outcomeId>inVpW2fMN9t</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Copy number variation database</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9A59A2A9-E2D8-45FC-82D0-ABD0FA8D13E4</gtr:id><gtr:title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_16517_27_23077024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B26D6742-7541-45A2-8829-AF3668A87F71</gtr:id><gtr:title>Mutations in the autoregulatory domain of ?-tubulin 4a cause hereditary dystonia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_16517_27_23424103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75562F86-F646-4880-A4E8-DFBBC548A374</gtr:id><gtr:title>Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/837b2dd55fd727fb4dddd9498f8bd733"><gtr:id>837b2dd55fd727fb4dddd9498f8bd733</gtr:id><gtr:otherNames>Lawton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>5a5c92a472bee8.50020664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A67C7B7-6D41-458D-8DA1-8C340A996250</gtr:id><gtr:title>Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1aa7d68da72e3547436051956af0d4cb"><gtr:id>1aa7d68da72e3547436051956af0d4cb</gtr:id><gtr:otherNames>Malek N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5a5c92a531e9c4.53265401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>865BD66C-85AD-4E94-B548-23807343CCCC</gtr:id><gtr:title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e2d0f395414b93ca8e16b698d9d8d12"><gtr:id>1e2d0f395414b93ca8e16b698d9d8d12</gtr:id><gtr:otherNames>International Parkinson Disease Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>oFgbttL15cK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>654679E8-6520-46F6-AEE4-BD13FAA069A8</gtr:id><gtr:title>Assessment of Parkinson's disease risk loci in Greece.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16517_27_24080174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D79ADB-6011-4624-91BD-DCC8D94B6AF2</gtr:id><gtr:title>Genome-wide association studies: the key to unlocking neurodegeneration?</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe26393ce1a826c37d2c03b54270978"><gtr:id>7fe26393ce1a826c37d2c03b54270978</gtr:id><gtr:otherNames>Gandhi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>KPPouHjgPqu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A86881A-FEB1-4D50-A59D-1C737A12189E</gtr:id><gtr:title>Mutations in HPCA cause autosomal-recessive primary isolated dystonia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80bdbfdd0b1d93ff7f53295d25d425e7"><gtr:id>80bdbfdd0b1d93ff7f53295d25d425e7</gtr:id><gtr:otherNames>Charlesworth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5697b16b71ae49.24371528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A4980A7-A025-489C-8BD4-83AEC5117D53</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16517_27_23223016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F27F276D-DE5C-473D-843C-98A78AF4969E</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5464b7e2ec89d4.85211994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5344186-4BD1-4526-BA01-DB97F0335D12</gtr:id><gtr:title>Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_16517_27_23645593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EA4FE9F-9E34-4372-B44E-27BA35A246E6</gtr:id><gtr:title>Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a5c92a5d08387.46900502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BE68940-718A-4BA8-B8AB-5F16828BA582</gtr:id><gtr:title>Parkinson's disease and cancer: two wars, one front.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b016b620411b3da51cfd468ebe3c2a"><gtr:id>81b016b620411b3da51cfd468ebe3c2a</gtr:id><gtr:otherNames>Devine MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-175X</gtr:issn><gtr:outcomeId>k6SucsMNiwA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C890652-09AA-42E5-9005-9C08387E3D6D</gtr:id><gtr:title>Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80bdbfdd0b1d93ff7f53295d25d425e7"><gtr:id>80bdbfdd0b1d93ff7f53295d25d425e7</gtr:id><gtr:otherNames>Charlesworth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_16517_27_23200863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B36D8162-DB7E-4366-A4A0-7EEBBEE4AC8C</gtr:id><gtr:title>Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data</gtr:title><gtr:parentPublicationTitle>Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c66d494b8c958ff042a6f23648ece61a"><gtr:id>c66d494b8c958ff042a6f23648ece61a</gtr:id><gtr:otherNames>Mok, Kin Y.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a5c92a4561285.09019871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77DB9ABD-7C7B-4A35-97C0-B160C6196299</gtr:id><gtr:title>Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eacf2f251ce8f5b9824dfa60f488e0b0"><gtr:id>eacf2f251ce8f5b9824dfa60f488e0b0</gtr:id><gtr:otherNames>Mittag F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_16517_27_22777693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DCF9937-2A13-48DB-8F5C-D434B3F26058</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>Hgz3pqm7wc2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF2794EE-D6E7-4C1A-B308-80D07D6855A6</gtr:id><gtr:title>Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8db82102989598335512733b4a848e6"><gtr:id>e8db82102989598335512733b4a848e6</gtr:id><gtr:otherNames>Norman BP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>5a360d73b8b553.99362303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B123D722-F9D0-4865-8584-B2A460860C0D</gtr:id><gtr:title>Establishing the role of rare coding variants in known Parkinson's disease risk loci.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aac30b01b744525ffc7d06e70f2732d7"><gtr:id>aac30b01b744525ffc7d06e70f2732d7</gtr:id><gtr:otherNames>Jansen IE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5a5c9560026bf1.21416715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A56426-867F-4E14-8F14-31CFA6E6E09E</gtr:id><gtr:title>Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5464b8c55fc7e0.88963759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B269D39-670D-465D-8E0C-2787A5278767</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed587de899b30ad5f3dce3fc99e9d0a"><gtr:id>5ed587de899b30ad5f3dce3fc99e9d0a</gtr:id><gtr:otherNames>Keller MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16517_27_22892372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B98A25F-5C2E-4BC6-9FA2-760DE9576026</gtr:id><gtr:title>An intragenic duplication in guanosine triphosphate cyclohydrolase-1 gene in a dopa-responsive dystonia family.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>hWRER5h3wZf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A037196-AB1B-4127-846A-07445602BCBA</gtr:id><gtr:title>Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5889d4fc200573.20473026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1F8E5CF-07C7-4543-9ECD-44E93F7B482F</gtr:id><gtr:title>Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d14c3a9646f0da9792d2b4276c13d04a"><gtr:id>d14c3a9646f0da9792d2b4276c13d04a</gtr:id><gtr:otherNames>Moskvina V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>56f0036285f469.91718043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27FFD391-5347-4249-96D9-F6941D38A5B2</gtr:id><gtr:title>NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c548daa91b19b3ab5594f4482ec73e2"><gtr:id>5c548daa91b19b3ab5594f4482ec73e2</gtr:id><gtr:otherNames>Blauwendraat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5a5c95608ec9e4.47847372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E531D21-887B-46EB-8057-53A5D652A48B</gtr:id><gtr:title>Young-onset parkinsonism due to homozygous duplication of a-synuclein in a consanguineous family.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a710ca1824f44073ef7bb8d23ab87321"><gtr:id>a710ca1824f44073ef7bb8d23ab87321</gtr:id><gtr:otherNames>Kojovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_16517_27_23283657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A004B481-B1EE-4F4B-A18B-2FD476EDD333</gtr:id><gtr:title>Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba827a97c3d3145072b7a8beef79432d"><gtr:id>ba827a97c3d3145072b7a8beef79432d</gtr:id><gtr:otherNames>Noyce AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a5c95603144f0.59415063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6FC3B21-D226-4893-BAD2-748C6C7E36EA</gtr:id><gtr:title>A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56decb810be899.62875922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13A6D4E4-006F-4727-9306-A955721E32A0</gtr:id><gtr:title>Genetic comorbidities in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16517_27_24057672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92FAE871-FEFE-4EE0-A56E-12DC04B60224</gtr:id><gtr:title>A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_16517_27_23588557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D7C5153-2AC6-4CC8-B931-34E531AE259C</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5464b8c62e6471.73557790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8874F338-E5BB-4A5C-9DBA-EFB47816848E</gtr:id><gtr:title>Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad3f4aad48683e6e281e5a2c104a3d81"><gtr:id>ad3f4aad48683e6e281e5a2c104a3d81</gtr:id><gtr:otherNames>UK Parkinson's Disease Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>oeYPfsWwcT2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B010AEA-D70C-4AAC-955C-4AD49ABD8C8F</gtr:id><gtr:title>Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_16517_27_23674490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF48A822-36F9-4685-8C9B-CC1149AE6B99</gtr:id><gtr:title>A robust model for read count data in exome sequencing experiments and implications for copy number variant calling.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5573c04333fe2be013ba5a135e3dabd6"><gtr:id>5573c04333fe2be013ba5a135e3dabd6</gtr:id><gtr:otherNames>Plagnol V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>pm_16517_27_22942019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEB7D9BE-9D05-4ABD-A23B-BEE67845F420</gtr:id><gtr:title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/405062aea31e15048134bff16a4a7b11"><gtr:id>405062aea31e15048134bff16a4a7b11</gtr:id><gtr:otherNames>Renton AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>rc3YDuex4tD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07C8A39A-AA2E-4981-9AC4-AECEC1056BDF</gtr:id><gtr:title>Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a35f9a35ca516.77085736</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_09003</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>